Rubella (German Measles): Symptoms, Vaccine & Pregnancy Risks

Medically reviewed | Last reviewed: | Evidence level: 1A
Rubella, commonly known as German measles, is a contagious viral infection characterized by a distinctive rash, swollen lymph nodes, and mild fever. While the illness is usually mild in children and adults, rubella poses serious risks during pregnancy, potentially causing congenital rubella syndrome (CRS) with severe birth defects. Thanks to widespread MMR vaccination, rubella has become rare in countries with high immunization rates, though it remains more common in parts of the world with lower vaccination coverage.
📅 Updated:
⏱️ Reading time: 12 minutes
Written and reviewed by iMedic Medical Editorial Team | Specialists in infectious diseases

📊 Quick Facts About Rubella

Incubation Period
14-21 days
from exposure to symptoms
Rash Duration
~3 days
hence "three-day measles"
Vaccine Efficacy
97%
after two MMR doses
Contagious Period
7 days before to 7 days after rash
via respiratory droplets
Pregnancy Risk
Up to 90%
CRS risk in first trimester
ICD-10 Code
B06
Rubella [German measles]

💡 Key Takeaways About Rubella

  • Rubella is different from measles: Despite the name "German measles," rubella is caused by a different virus and is generally milder than measles (rubeola)
  • Pregnancy is the major concern: Rubella infection during the first 16 weeks of pregnancy can cause congenital rubella syndrome with severe birth defects
  • MMR vaccine prevents rubella: Two doses of the measles-mumps-rubella vaccine provide approximately 97% protection against rubella
  • Many cases are asymptomatic: Up to 50% of people infected with rubella may have no symptoms or feel only mildly ill
  • Lifelong immunity after infection: Once you've had rubella, you cannot get it again - natural infection provides permanent immunity
  • Check immunity before pregnancy: Women planning pregnancy should verify their rubella immunity through a blood test

What Is Rubella and What Causes It?

Rubella is a contagious viral infection caused by the rubella virus, a member of the Togaviridae family. It spreads through respiratory droplets when an infected person coughs or sneezes, and is characterized by a distinctive pink rash, swollen lymph nodes, and mild fever. The illness is usually mild but can cause serious birth defects if contracted during pregnancy.

Rubella, historically known as German measles or three-day measles, is an acute viral infection that has been recognized since the 18th century. The name "German measles" originated because German physicians first described the illness as distinct from measles and scarlet fever in the mid-1700s. Despite this historical name, rubella has no particular connection to Germany - it occurs worldwide and is caused by an entirely different virus than measles (rubeola).

The rubella virus is a single-stranded RNA virus that belongs to the genus Rubivirus within the Togaviridae family. Unlike many other viruses, humans are the only known natural host for the rubella virus, which means the disease can only spread from person to person. This characteristic has made global elimination of rubella a realistic public health goal through widespread vaccination programs.

Before the development and widespread use of the rubella vaccine in the late 1960s, rubella epidemics occurred approximately every 6-9 years, affecting millions of people worldwide. The most devastating consequence of these epidemics was congenital rubella syndrome (CRS), which occurred when pregnant women became infected and transmitted the virus to their developing babies. The 1964-1965 rubella epidemic in the United States alone resulted in an estimated 12.5 million cases and approximately 20,000 babies born with CRS.

How Rubella Spreads

The rubella virus spreads primarily through respiratory droplets expelled when an infected person coughs, sneezes, or talks. These droplets can travel short distances through the air and be inhaled by nearby individuals, or they can contaminate surfaces where the virus can survive for several hours. Direct contact with infected respiratory secretions can also transmit the disease.

One of the challenges in controlling rubella spread is that infected individuals are contagious for an extended period. A person with rubella can spread the virus from approximately one week before the rash appears until one to two weeks after the rash develops. This means that people can unknowingly transmit the virus before they realize they're ill. Additionally, because up to 50% of rubella infections cause no symptoms or only very mild illness, infected individuals may spread the virus without ever knowing they were infected.

Why Rubella Is Different from Measles

Although rubella is sometimes called German measles, it's important to understand that it is a completely different disease from measles (rubeola). The two diseases are caused by different viruses from different viral families, produce different symptoms, and have different potential complications. Measles is generally a more severe illness with higher fever, more pronounced respiratory symptoms, and distinctive Koplik's spots inside the mouth. The measles rash is also different - it's typically more blotchy and red, while the rubella rash is finer and pinker.

The most significant difference between the two diseases relates to their effects during pregnancy. While both can cause problems if contracted during pregnancy, rubella is far more likely to cause severe birth defects. This is why rubella immunity is specifically checked during prenatal care, and why the rubella component of the MMR vaccine is so crucial for women of childbearing age.

What Are the Symptoms of Rubella?

Rubella symptoms include a fine, pink rash that starts on the face and spreads downward, swollen lymph nodes (especially behind the ears and at the back of the neck), low-grade fever, runny nose, and joint pain. Symptoms typically appear 14-21 days after exposure and the rash usually lasts about 3 days. Many people with rubella experience no symptoms at all.

Rubella is often described as a mild illness, and this characterization is generally accurate - especially when compared to many other infectious diseases. However, the symptoms can vary considerably from person to person. Some individuals experience classic symptoms that make the diagnosis fairly straightforward, while others may have such mild symptoms that they don't realize they're ill. Understanding the full spectrum of rubella symptoms is important for early recognition and prevention of spread to vulnerable individuals, particularly pregnant women.

The incubation period for rubella - the time between exposure to the virus and the appearance of symptoms - is typically 14 to 21 days, with an average of about 16-18 days. This relatively long incubation period means that by the time symptoms appear, an infected person may have already unknowingly exposed many others to the virus.

Early Symptoms (Prodrome)

Before the characteristic rash appears, many people with rubella experience a prodromal phase lasting 1-5 days. These early symptoms are often non-specific and may be mistaken for a common cold or other minor illness. The prodromal symptoms of rubella typically include:

  • Low-grade fever: Usually below 39°C (102°F), often so mild it goes unnoticed
  • Runny nose (rhinitis): Clear nasal discharge similar to a cold
  • Mild conjunctivitis: Pink or red eyes without significant discharge
  • Swollen lymph nodes: Particularly noticeable behind the ears (post-auricular) and at the back of the neck (suboccipital)
  • General malaise: Feeling slightly unwell or tired
  • Headache: Usually mild

The swollen lymph nodes are particularly characteristic of rubella and often appear before the rash. They may be tender to the touch and can persist for several weeks after other symptoms have resolved. This lymph node swelling, especially in the post-auricular and suboccipital regions, can help distinguish rubella from other viral illnesses that cause rashes.

The Rubella Rash

The hallmark of rubella is its distinctive rash, which typically appears about 14-17 days after exposure to the virus. The rubella rash has several characteristic features that help distinguish it from other viral exanthems (rash-causing illnesses):

  • Appearance: Fine, pink or light red spots (maculopapular) that may merge together
  • Starting location: The rash typically begins on the face and behind the ears
  • Spread pattern: It spreads downward to the neck, trunk, and then to the arms and legs over about 24-48 hours
  • Duration: The rash usually lasts approximately 3 days (hence the historical name "three-day measles")
  • Resolution: The rash fades in the same order it appeared - face first, then downward
Important Note About Skin Tone:

The rubella rash may appear differently depending on skin tone. On lighter skin, the rash typically appears as pink or light red spots. On darker skin, the rash may be more difficult to see visually but can often be felt as slightly raised bumps. The rash may appear more subtle or have a different color, appearing as darker spots or being visible mainly in areas where the skin is lighter. Healthcare providers should examine the skin carefully and consider other symptoms when evaluating individuals with darker skin tones.

Joint Pain and Arthritis

One of the more troublesome symptoms of rubella, particularly in adolescents and adults, is joint pain (arthralgia) or actual joint inflammation (arthritis). This symptom is much more common in women than in men and can occur in up to 70% of adult women who contract rubella. The joint symptoms typically:

  • Begin around the time the rash appears or shortly after
  • Affect the fingers, wrists, and knees most commonly
  • Cause pain, swelling, and stiffness
  • Last from a few days to about two weeks
  • Rarely cause permanent joint damage

Asymptomatic Infection

A significant proportion of rubella infections - estimated at 25-50% - cause no noticeable symptoms at all. This is called subclinical or asymptomatic infection. While this might seem like good news for the infected individual, it actually presents a significant public health challenge. People with asymptomatic infection can still spread the virus to others, including pregnant women, without anyone realizing they're contagious. This is one reason why vaccination is so important - it protects not only the vaccinated individual but also prevents them from unknowingly spreading the virus to vulnerable people.

Rubella Symptoms by Age Group and Severity
Symptom Children Adults Typical Duration
Rash Common, mild Common 2-3 days
Fever Low-grade or absent Low to moderate 1-2 days
Lymph node swelling Common Very common 1-2 weeks or longer
Joint pain Rare Common (especially women) Days to 2 weeks

When Should You Seek Medical Care for Rubella?

Seek medical care if you suspect rubella and have been in contact with pregnant women, if you're pregnant and have been exposed to rubella, or if you develop severe symptoms like high fever, severe headache, or stiff neck. Always call your healthcare provider before visiting to prevent spreading the infection to others in the waiting room.

Because rubella is usually a mild illness that resolves on its own, many people with rubella don't need to seek medical care. However, there are several important situations where medical evaluation is necessary or advisable.

Contact your healthcare provider if:

  • You suspect you have rubella and have had contact with pregnant women who may not be immune
  • You are pregnant and have been exposed to someone with rubella or suspect you may have been exposed
  • You are pregnant and develop a rash of any kind
  • You develop symptoms that are more severe than expected, such as high fever, severe headache, confusion, or stiff neck
  • Joint pain or swelling is severe or persists longer than two weeks
  • You have concerns about your immunity status and are planning pregnancy
🚨 Important: Call Before You Visit

If you suspect you have rubella, call your healthcare provider before going to the clinic. This allows the office to take precautions to prevent you from exposing pregnant women or other vulnerable individuals in the waiting room. You may be asked to enter through a different entrance or wait in a separate area. This simple step can help protect others from a potentially serious infection.

Rare but Serious Complications

While rubella complications are rare in otherwise healthy individuals, they can occur. Seek immediate medical attention if you or someone with rubella develops:

  • Severe headache with stiff neck (possible encephalitis)
  • Unusual bleeding or bruising (possible thrombocytopenia)
  • Difficulty breathing
  • High fever that doesn't respond to fever-reducing medication
  • Confusion or changes in consciousness

Why Is Rubella Dangerous During Pregnancy?

Rubella during pregnancy, especially in the first 16 weeks, can cause congenital rubella syndrome (CRS) in the developing baby. CRS can result in deafness, heart defects, cataracts, intellectual disabilities, liver and spleen damage, and other serious problems. The risk is highest (up to 90%) if infection occurs in the first 12 weeks of pregnancy.

While rubella is typically a mild illness for the person who contracts it, the consequences for an unborn baby can be devastating. When a pregnant woman becomes infected with rubella, the virus can cross the placenta and infect the developing fetus. This can result in congenital rubella syndrome (CRS), a collection of serious birth defects that can affect virtually every organ system in the body.

The risk of CRS and its severity depend heavily on the gestational age when infection occurs. The fetus is most vulnerable during the first trimester when critical organ systems are forming. Studies have shown the following risk patterns:

  • First 12 weeks of pregnancy: Up to 85-90% risk of congenital infection, with high rates of severe defects
  • 13-16 weeks: Approximately 50-60% risk of congenital infection, primarily causing deafness
  • After 16 weeks: Risk decreases significantly, though some complications can still occur
  • After 20 weeks: Congenital defects are rare, though intrauterine growth restriction may occur

Congenital Rubella Syndrome (CRS)

Congenital rubella syndrome encompasses a wide range of birth defects. The classic triad of CRS includes cataracts, heart defects, and deafness, but many other problems can occur. Common manifestations of CRS include:

  • Hearing impairment: The most common single defect, affecting up to 80% of CRS cases; often severe and may be the only abnormality
  • Eye abnormalities: Cataracts, glaucoma, retinopathy, and microphthalmos (abnormally small eyes)
  • Heart defects: Patent ductus arteriosus, pulmonary artery stenosis, and ventricular septal defects
  • Neurological problems: Intellectual disability, developmental delay, and behavioral disorders
  • Growth problems: Low birth weight and failure to thrive
  • Blood disorders: Thrombocytopenia (low platelets) and anemia
  • Liver and spleen enlargement: Hepatosplenomegaly
  • Bone abnormalities: Visible on X-ray

Children born with CRS may also continue to shed the rubella virus for extended periods - sometimes up to a year or more after birth - making them potentially contagious to others, including pregnant women. This prolonged viral shedding requires special precautions in healthcare and childcare settings.

⚠️ Pregnancy Planning Recommendation

All women of childbearing age should know their rubella immunity status before becoming pregnant. A simple blood test can determine if you have protective antibodies. If you're not immune, you should receive the MMR vaccine and then wait at least one month before becoming pregnant. The vaccine cannot be given during pregnancy because it contains live virus, but vaccination after delivery protects future pregnancies.

What to Do If Exposed During Pregnancy

If you're pregnant and have been exposed to someone with rubella, or suspect you might have rubella, contact your healthcare provider immediately. They will likely:

  1. Review your vaccination history and any previous rubella immunity testing
  2. Order blood tests to check for rubella antibodies (both IgG and IgM)
  3. Discuss the level of risk based on your gestational age and exposure details
  4. Arrange follow-up testing if needed to determine if infection has occurred
  5. Provide counseling about options and monitoring if infection is confirmed

Should Children with Rubella Stay Home?

Yes, children with rubella should stay home for at least 7 days after the rash appears to prevent spreading the infection to others, especially pregnant women. They should also be fever-free for 24 hours without fever-reducing medication and feel well enough to participate in normal activities before returning to school or childcare.

Isolation of individuals with rubella is an important public health measure to prevent spread of the virus, particularly to pregnant women who may not be immune. While the child may feel well enough to attend school after just a few days, they can still be contagious.

The general guidelines for rubella isolation include:

  • Stay home for at least 7 days after the rash first appears
  • Be fever-free for at least 24 hours without using fever-reducing medication
  • Feel well enough to participate in normal daily activities
  • Avoid contact with pregnant women or immunocompromised individuals during the contagious period

During the isolation period, the child should avoid public places, particularly healthcare facilities, schools, and childcare centers where pregnant women might be present. Family members and caregivers should also take precautions, especially if any household members are pregnant or planning pregnancy.

How Does the MMR Vaccine Protect Against Rubella?

The MMR (measles, mumps, rubella) vaccine provides approximately 97% protection against rubella after two doses. The first dose is typically given at 12-15 months of age, and the second dose at 4-6 years. The vaccine contains live weakened virus that stimulates the immune system to produce protective antibodies without causing disease.

The rubella vaccine is one of the most effective vaccines ever developed and has dramatically reduced rubella cases worldwide since its introduction in the late 1960s. Today, the rubella vaccine is given as part of the combination MMR vaccine, which protects against measles, mumps, and rubella simultaneously.

The rubella vaccine contains a live but weakened (attenuated) form of the rubella virus. When administered, this weakened virus stimulates the immune system to produce antibodies against rubella without causing the actual disease. These antibodies provide long-lasting protection - in most cases, immunity from the vaccine lasts for life, similar to immunity from natural infection.

Vaccination Schedule

The recommended vaccination schedule for rubella (as part of the MMR vaccine) includes two doses:

  • First dose: 12-15 months of age
  • Second dose: 4-6 years of age (typically before starting school)

The second dose is not a "booster" in the traditional sense - it's given to provide protection to the small percentage of people who don't respond adequately to the first dose. After two doses, approximately 97% of recipients will have protective antibodies against rubella.

Who Should Be Vaccinated

MMR vaccination is recommended for:

  • All children as part of the routine childhood immunization schedule
  • Adults born after 1957 who don't have evidence of immunity (those born before 1957 are generally considered immune due to likely natural infection)
  • Healthcare workers, regardless of birth year
  • International travelers
  • Women of childbearing age who are not pregnant and don't have evidence of rubella immunity
  • College students and other young adults in group living situations

Who Should Not Receive the Vaccine

Because the MMR vaccine contains live virus, certain individuals should not receive it or should delay vaccination:

  • Pregnant women: Should not receive MMR vaccine; wait until after delivery
  • Severely immunocompromised individuals: Including those with certain cancers, HIV/AIDS with low CD4 counts, or receiving immunosuppressive therapy
  • People with severe allergic reactions: To previous MMR doses or vaccine components (such as neomycin or gelatin)
  • Those recently receiving blood products: May need to wait before vaccination
After MMR Vaccination:

Women who receive the MMR vaccine should wait at least one month before becoming pregnant. While no cases of congenital rubella syndrome have been documented from inadvertent vaccination during pregnancy, this precaution is recommended because the vaccine contains live virus. If you receive the vaccine and then discover you're pregnant, notify your healthcare provider, but rest assured that the risk appears to be very low or nonexistent.

How Is Rubella Treated?

There is no specific antiviral treatment for rubella - the infection resolves on its own within about a week. Treatment focuses on relieving symptoms with rest, fluids, and over-the-counter medications for fever and discomfort. Joint pain may require anti-inflammatory medications. Prevention through vaccination is the key strategy for controlling rubella.

Unlike some viral infections for which antiviral medications exist, there is no specific treatment that targets the rubella virus itself. Fortunately, rubella is usually a mild, self-limiting illness that resolves within a week or so without any specific treatment. Care is focused on supportive measures to keep the patient comfortable while the immune system clears the infection.

Supportive Care at Home

For most people with rubella, home care is sufficient. Recommended measures include:

  • Rest: Allow the body to focus energy on fighting the infection
  • Hydration: Drink plenty of fluids, especially if fever is present
  • Fever management: Acetaminophen (paracetamol) or ibuprofen can help reduce fever and discomfort; aspirin should be avoided in children and teenagers due to the risk of Reye's syndrome
  • Joint pain relief: Non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen can help with joint pain in adults
  • Cool compresses: May help with any discomfort from the rash or swollen lymph nodes

Managing Joint Symptoms

For adults, particularly women, who develop significant joint pain or arthritis, additional measures may be needed:

  • Rest affected joints
  • Apply warm or cool compresses as preferred
  • Take NSAIDs for pain and inflammation (with food to protect the stomach)
  • Consider physical therapy exercises to maintain mobility
  • Contact your healthcare provider if symptoms are severe or persist beyond two weeks

How Does Rubella Spread and How Long Is It Contagious?

Rubella spreads through respiratory droplets when an infected person coughs or sneezes. The virus can also survive on surfaces for several hours. A person is contagious from about 7 days before the rash appears until 7-14 days after. The incubation period is 14-21 days, meaning people can spread the virus before they know they're infected.

Understanding how rubella spreads is crucial for preventing transmission, particularly to pregnant women. The rubella virus is present in the respiratory secretions of infected individuals, including their saliva, mucus, and the droplets expelled during coughing, sneezing, or even talking.

The primary modes of transmission include:

  • Respiratory droplets: The main route of transmission; droplets from an infected person can be inhaled by others nearby
  • Direct contact: Touching infected respiratory secretions and then touching one's nose, mouth, or eyes
  • Contaminated surfaces: The virus can survive on surfaces for several hours, allowing indirect transmission
  • Vertical transmission: A pregnant woman can transmit the virus to her fetus through the placenta

Timeline of Contagiousness

The contagious period for rubella is extensive, which contributes to its ability to spread through communities:

  • Before symptoms: Contagious starting approximately 7 days before the rash appears
  • Peak contagiousness: The few days before and after the rash appears
  • After rash: Remains contagious for 7-14 days after the rash develops
  • Infants with CRS: May shed virus for a year or more after birth

The fact that people are contagious before they develop symptoms makes rubella particularly challenging to control through isolation alone. By the time someone realizes they have rubella, they may have already exposed many others. This is why vaccination - which prevents infection in the first place - is the most effective strategy for controlling rubella.

How Can You Prevent Rubella?

The most effective way to prevent rubella is through MMR vaccination, which provides 97% protection after two doses. Other prevention measures include avoiding contact with infected individuals, practicing good hand hygiene, and ensuring immunity before pregnancy. Herd immunity from high vaccination rates protects those who cannot be vaccinated.

Prevention of rubella relies primarily on vaccination, but other measures also play important roles, especially for protecting pregnant women and other vulnerable individuals.

Vaccination: The Primary Prevention Strategy

Widespread vaccination is the most effective way to prevent rubella and its serious complications. High vaccination coverage provides both individual protection and herd immunity - when enough people in a community are immune, the virus cannot spread easily, protecting even those who cannot be vaccinated (such as pregnant women and immunocompromised individuals).

To maintain effective herd immunity against rubella, approximately 85-90% of the population needs to be immune. Many countries have achieved this level through routine childhood vaccination programs.

Pre-Pregnancy Planning

For women planning pregnancy, several steps can help ensure protection against rubella:

  • Have a blood test to check for rubella immunity before becoming pregnant
  • If not immune, get vaccinated and wait at least one month before trying to conceive
  • Keep vaccination records for reference
  • Ensure other household members are up-to-date on MMR vaccination

General Prevention Measures

When rubella is circulating in a community, additional precautions include:

  • Avoid contact with sick individuals: Especially if pregnant or of unknown immune status
  • Hand hygiene: Wash hands frequently with soap and water or use alcohol-based hand sanitizer
  • Avoid touching face: Don't touch your eyes, nose, or mouth with unwashed hands
  • Clean shared surfaces: Regularly disinfect commonly touched surfaces
  • Stay informed: Be aware of any rubella outbreaks in your area

Frequently Asked Questions About Rubella

Medical References and Sources

This article is based on current medical research and international guidelines. All claims are supported by scientific evidence from peer-reviewed sources.

  1. World Health Organization (2020). "Rubella vaccines: WHO position paper." Weekly Epidemiological Record, 95(27), 306-324. Evidence level: 1A
  2. Centers for Disease Control and Prevention (2024). "Pink Book: Rubella." CDC Epidemiology and Prevention Comprehensive reference for rubella epidemiology and prevention.
  3. European Centre for Disease Prevention and Control (2023). "Rubella - Annual Epidemiological Report." ECDC surveillance report on rubella in European countries.
  4. Reef SE, et al. (2020). "Progress Toward Control of Rubella and Prevention of Congenital Rubella Syndrome." MMWR Morbidity and Mortality Weekly Report. Evidence level: 1A
  5. Grant GB, et al. (2021). "Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination." MMWR Morbidity and Mortality Weekly Report, 70(23):806-811.
  6. Banatvala JE, Brown DWG. (2004). "Rubella." The Lancet, 363(9415), 1127-1137. Classic review article on rubella.

About Our Medical Editorial Team

This article was written and reviewed by iMedic's medical editorial team, which includes specialists in infectious diseases, pediatrics, and public health. Our team follows strict editorial guidelines based on evidence-based medicine principles.

Evidence-Based Approach

All content is based on peer-reviewed research, international guidelines (WHO, CDC, ECDC), and systematic reviews. We use the GRADE framework to evaluate evidence quality.

Regular Updates

Medical content is reviewed regularly and updated when new evidence emerges. This article was last reviewed on .

Questions or corrections? Contact our medical team at iMedic Contact.